BRAF and ovarian neoplasm: The inverse association between BRAF and RAS in alternative activation of MEK/MAPK signaling in many tumors [35], including colon [36] and ovarian tumors [37], inspired Cohen et al. to explore the role of BRAF in the predominantly RAS-negative PTC.